Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Xilis

company

About

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Details

Last Funding Type
Series A
Last Funding Money Raised
$19M
Industries
Biotechnology,Health Care,Health Diagnostics,Life Science,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Xilis Inc.

Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster.

It was founded in 2019 and is headquartered in Durham, North Carolina.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$92M
Xilis has raised a total of $92M in funding over 2 rounds. Their latest funding was raised on Jul 13, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 13, 2022 Series A $19M 11 FPV Ventures Detail
Jul 8, 2021 Series A $70M 10 Mubadala Capital Ventures Detail
May 5, 2020 Seed 3 Two Sigma Ventures Detail
Dec 10, 2019 Seed $3M 4 Felicis Ventures Detail

Investors

Number of Lead Investors
Number of Investors
4
15
Xilis is funded by 15 investors. FPV Ventures and Alexandria Venture Investments are the most recent investors.
Investor Name Lead Investor Funding Round
FPV Ventures Yes Series A
Alexandria Venture Investments Series A
Alix Ventures Series A
Catalio Capital Management Series A
Duke Angel Network Series A
EQT AB Series A
Felicis Ventures Series A
GV Series A
Mubadala Capital Ventures Series A
Pear VC Series A

Employee Profiles

Number of Employee Profiles
20
Xilis has 20 current employee profiles, including Executive David Hsu
Executive
Advisor
Advisor
Advisor
Employee